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Abstract
Objective: Ghrelin acylation by ghrelin O-acyltransferase (GOAT) has recently been reported to be essential for the
prevention of hypoglycemia during prolonged negative energy balance. Using a unique set of four different genetic loss-of-
function models for the GOAT/ghrelin/growth hormone secretagogue receptor (GHSR) system, we thoroughly tested the
hypothesis that lack-of-ghrelin activation or signaling would lead to hypoglycemia during caloric deprivation.
Methodology: Male and female knockout (KO) mice for GOAT, ghrelin, GHSR, or both ghrelin and GHSR (dKO) were
subjected to prolonged calorie restriction (40% of ad libitum chow intake). Body weight, fat mass, and glucose levels were
recorded daily and compared to wildtype (WT) controls. Forty-eight hour blood glucose profiles were generated for each
individual mouse when 2% or less body fat mass was reached. Blood samples were obtained for analysis of circulating levels
of acyl- and desacyl-ghrelin, IGF-1, and insulin.
Principal Findings: Chronic calorie restriction progressively decreased body weight and body fat mass in all mice regardless
of genotype. When fat mass was depleted to 2% or less of body weight for 2 consecutive days, random hypoglycemic
events occurred in some mice across all genotypes. There was no increase in the incidence of hypoglycemia in any of the
four loss-of-function models for ghrelin signaling including GOAT KO mice. Furthermore, no differences in insulin or IGF-1
levels were observed between genotypes.
Conclusion: The endogenous GOAT-ghrelin-GHSR system is not essential for the maintenance of euglycemia during
prolonged calorie restriction.
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Introduction
Ghrelin is a 28 amino acid polypeptide with a fatty acid
esterified to its serine-3 residue [1]. Such esterification, catalyzed
by the enzyme ghrelin O-acyl transferase (GOAT) [2,3], is
essential to activate the only known ghrelin receptor (GHSR) [4].
Administration of acyl-ghrelin increases food intake and
adiposity in mammals [5]. Also, acyl-ghrelin has been shown
to inhibit insulin secretion in rodents [6] and humans [7].
Conversely, desacyl-ghrelin has been shown to have either no
effect [8], or beneficial effects on insulin sensitivity [9] and
insulin secretion [10]. In addition, desacyl- and acyl-ghrelin
might be endogenous opponents in systemic regulation of
glucose metabolism [11].
It was recently reported that mice lacking GOAT were unable
to maintain euglycemia during prolonged caloric restriction [12],
while wildtype (WT) controls did. Such impairment was
prevented when mice were treated with acyl-ghrelin. Here, we
aimed to expand these findings by using four different loss-of-
function models to systematically dissect the potential role of each
component of the ghrelin system in protecting against hypogly-
cemia during chronic calorie restriction. Specifically, we tested
the hypothesis that severe and chronic calorie deprivation would
cause increased incidence of hypoglycemic events using A)
GOAT KO mice which lack ghrelin acylation, B) GHSR KO
mice which lack acyl-ghrelin induced signaling C) ghrelin KO
mice which lack both acyl- and desacyl-ghrelin, and D) ghrelin/
GHSR double KO mice which lack all known ligands and
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functions of GOAT.
Results
Comparable loss of body weight and fat mass in WT and
ghrelin loss-of-function mouse models under prolonged
CR
When calories were restricted to 40% of ad libitum food intake,
WT, GOAT KO, ghrelin KO, GHSR KO and ghrelin-GHSR
dKO mice showed a consistent decrease in body weight (BW)
(Figures 1A, 1C and S1A, S1C, left panels) and fat mass
(Figures 1B, 1D and S1B, S1D, right panels). Regardless of
genotypes, the rate of fat mass loss in female mice was less rapid
under CR (Figures 1D and S1D) as compared to their male
counterparts, allowing female mice to persist longer on the CR
regime. Of note, the average losses of body weight and fat mass
were identical among genotypes (data not shown), while inter-
individual variability was considerable throughout all groups. To
account for these large differences within genotypes, data were also
analyzed separately for all individuals within their respective
genotypes. Although not reaching statistical significance, GHSR
KO and dKO mice tended to show lower initial body weight and
fat mass (Table 1). According to IACUC regulations, CR was
continued until mice lost all of their fat mass for two consecutive
days, or when hypoglycemia (BG,50 mg/dL for 2 consecutive
measurements) occurred.
Hypoglycemic events in WT and ghrelin loss-of-function
models after prolonged CR were rare and genotype-
independent
CR rapidly decreased blood glucose within days; however, the
vast majority of mice, regardless of genotype or gender, adapted
rapidly to the decreased energy availability and maintained
euglycemia (Figures 2 and S2). Overall, blood glucose levels
appeared more stable in female mice (Figures 2B and S2B), with
rare events of hypoglycemia within the first 20 days of CR, while
male mice appeared to become hypoglycemic more frequently
(Figures 2A and S2A). However, there was no significant
difference among genotypes.
Importantly, all hypoglycemic events, regardless of gender or
genotype, were preceded by a complete loss of body fat mass (0%).
It should also be noted that multiple animals from both genders
and all genotypes (in total ,91%), despite losing all fat mass for
Figure 1. Change of body weight and fat mass in WT and ghrelin-loss-of-function mice after chronic CR. Male (A,B) and female (C,D)
wildtype (WT) and GOAT, Ghrelin (Ghr), GHSR, or Ghr-GHSR dKO mice were subjected to chronic CR (40% of ad libitum calories), and changes in body
weight (A,C) and fat mass (B,D) were recorded. Values are shown for each individual animal. Mice were taken out of the CR regiment when fat mass
dropped to 0% for 2 consecutive days, or when mice became severely hypoglycemic. Lines depict body weight and fat mass curves for individual
animals from groups of 8 male GOAT WT, 5 female GOAT WT, 9 male GOAT KO, 8 female GOAT KO, 10 male Ghr-GHSR dWT, 20 female Ghr-GHSR dWT,
19 male Ghr KO, 18 female Ghr KO, 7 male GHSR KO, 19 female GHSR KO, 16 male Ghr-GHSR dKO and 7 female Ghr-GHSR dKO mice.
doi:10.1371/journal.pone.0032100.g001
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termination of studies. Table 1 displays the incidence of
hypoglycemia vs. euglycemia in all tested genders and groups.
No increased incidence of hypoglycemic events in
calorically restricted loss-of-ghrelin-function mouse
models with 2% or less body fat
When body fat mass was reduced to ,2%, blood glucose levels
at both 8am and 2:30pm (2 h after the onset, and 3.5 h before the
end of the light phase, respectively) did not differ between the male
or female KOs and their WT controls, respectively (Figure 3A,
3B). Similarly, blood glucose levels did not fall significantly when
body fat mass was fully depleted to 0% for two consecutive days
(Figure 3C, 3D). Intriguingly, on the second day of reaching 0%
body fat, the GOAT KO females tended to have decreased blood
glucose levels (p=0.0685, GOAT WT vs. GOAT KO).
In CR mice, loss-of-ghrelin-function does not affect IGF-1
or insulin levels
After prolonged CR with a complete loss of fat mass, insulin and
IGF-1 levels were similar among genotypes in both male and
female mice (Table 1). As expected, acyl-ghrelin was not
detectable in the GOAT KO groups. Plasma desacyl-ghrelin
levels were significantly higher in male GOAT KO mice
compared to WT controls.
Discussion
A recent series of elegant studies reported by Zhao and
colleagues suggested that ghrelin acylation by GOAT is essential
for the prevention of hypoglycemia during CR [12] and provided
an intriguing set of data suggestive of a key mechanistic role for
ghrelin-induced GH secretion. Specifically, mice lacking GOAT
rapidly dropped blood glucose levels below 20 mg/dl when
chronically fed only 40% of their normal calories. Infusion of
acyl-ghrelin rescued the GOAT-deficient mice from hypoglyce-
mia, potentially by reinstating a steady release of GH. Not
unexpectedly, direct GH infusion rescued the GOAT-deficient
mice from hypoglycemia [12].
In our study, we failed to observe any CR-induced hypoglyce-
mia associated with loss of ghrelin function, and the absence of
acyl-ghrelin did not facilitate CR-induced hypoglycemia. Our data
are in agreement with results provided by Sun et al., who
implemented a 50% calorie restricted diet for 40 days in 10-week
old Ghrelin KO and GHSR KO mice [13]. Both knockout models
experienced decreased blood glucose levels compared to their WT
littermates during the early phases of CR. However, after
Table 1. Number, age, initial vs. final body morphometry, and final acyl/desacyl-ghrelin, insulin and IGF-1 plasma levels of loss-of
function ghrelin or their respective WT control mice after CR.
GOAT WT GOAT KO Ghrelin-GHSR WT Ghrelin KO GHSR KO Ghrelin-GHSR dKO
Number of mice Male 5 9 10 19 7 16
Female 8 8 20 8 19 7
Age [weeks] Male 35.163 45.163.3 27.161.4 31.663.3 28.762.1 29.061
Female 39.762.7 37.862.6 30.361.5 34.662.2 29.960.8 28.461.5
Initial BW [g] Male 32.860.5 33.360.8 32.360.6 30.860.7 29.760.4 31.261
Female 26.160.7 25.360.8 25.660.5 27.260.5 25.260.5 22.960.9
{
Final BW [g] Male 20.360.7 21.860.8 21.060.3 20.960.4 21.060.4 20.960.5
Female 16.160.4 16.560.4 17.160.3 17.660.4 16.660.3 17.061.4
Initial Fat Mass [%] Male 17.763.7 14.6671 2 . 7 63.6 10.663.2 7.663.7
{ 12.664.6
Female 14.661.1 13.161.1 9.960.6 12.060.7
{{ 14.961.1 10.761.3
Hypoglycemia
1 M a l e 0o f5 0o f9 0o f1 0 1o f1 9 1o f7 0o f1 6
F e m a l e 1o f8 1o f8 3o f2 0 1o f7 3o f1 9 1o f7
Desacyl-ghrelin [pg/ml] Male 164691 6296104** 2066102 n.d. 4116175 n.d.
Female 84633 158644 1668 n.d. 62633 n.d.
Acyl-ghrelin [pg/ml] Male 12516303 0.660.6** 11426205 n.d. 9956134 n.d.
Female 15916246 n.d. 6506128 n.d. 11486249 n.d.
Insulin [ng/ml] Male 0.6360.08
a 0.7660.08 0.5460.09 0.4260.04 0.5760.04 0.5360.04
Female 0.5360.19
b 0.8060.09
c 0.4060.05 0.6160.17 0.4260.06 0.5060.09
IGF-1 [ng/ml] Male 156653 220632 148625 160618 131632 192615
Female 131641
b 154642
c 103619 125633 121620 123628
Data are shown as Mean 6 SEM. ‘‘n.d.’’ indicates not detectable;
*p,0.05,
**p,0.001 vs. GOAT WT;
{p,0.05,
{{p,0.01 vs. Ghrelin-GHSR WT;
1Number of mice removed from studies with two consecutive hypoglycemic events of blood glucose levels #50 mg/dL;
an=4;
bn=3;
cn=4.
doi:10.1371/journal.pone.0032100.t001
Ghrelin, Hypoglycemia and CR
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e32100prolonged CR all mice displayed similar blood glucose levels and
neither group of knockout mice experienced severe hypoglycemia
during any phase of CR [13]. In addition, according to Lucidi
et al. [14], ghrelin was not essential for the activation of the
defense mechanism against acute insulin-induced hypoglycemia;
rather, they could demonstrate that despite low ghrelin levels
counter-regulatory hormones like GH, cortisol and glucagon
increased in response to hypoglycemia.
Although we used a nearly identical paradigm and light-dark
cycle for the food restriction and blood glucose measurements, we
had to implement a number of methodological changes. For
instance, we measured blood glucose from tail snips by using hand
held glucometers, while Zhao et al. used isoflurane anesthesia and
retro-orbital bleeding to allow for daily collection of significantly
larger amounts of blood for additional measurements of ghrelin
and GH [12]. Such higher invasiveness in the studies of Zhao et al.
might have contributed to the more dramatic blood glucose
decrease observed in their experimental mice. Another striking
difference was the amount of fat mass at which hypoglycemia
occurred in the study of Zhao et al.; GOAT-deficient mice
experienced hypoglycemia after 4 days but fat mass appeared to
stabilize at 2% [12]. In our study, fat mass dropped to 0% in
almost all mice after prolonged CR. Notably, however, most mice
in our study, regardless of the presence or absence of acyl- or
desacyl-ghrelin, were able to maintain euglycemia despite a
complete loss of fat mass for 48 hrs.
Next to the experimental paradigm, a relative abundance of
carbohydrates in our diet (58% compared to 49% in [12]) might
Figure 2. Effects of chronic CR on blood glucose levels. Chronic CR (40% of ad libitum calories) decreased glucose levels in male (A) and female
(B) wildtype (WT) and GOAT, Ghrelin (Ghr), GHSR, or Ghr-GHSR dKO mice. However, ghrelin loss-of function did not increase the risk for hypoglycemia,
compared to the respective WT mice. Values are shown for each individual animal. Mice were taken out of the CR regiment when either fat mass
dropped to 0% for 2 consecutive days, or when mice became hypoglycemic. Lines depict glucose levels for individual animals from groups of 8 male
GOAT WT, 5 female GOAT WT, 9 male GOAT KO, 8 female GOAT KO, 10 male Ghr-GHSR dWT, 20 female Ghr-GHSR dWT, 19 male Ghr KO, 18 female Ghr
KO, 7 male GHSR KO, 19 female GHSR KO, 16 male Ghr-GHSR dKO and 7 female Ghr-GHSR dKO mice.
doi:10.1371/journal.pone.0032100.g002
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addition, although gene targeting strategies were mostly identical
(VelociGene by Regeneron Pharmaceuticals [12,15]), the partially
mixed background of the GOAT KO mice used by Zhao et al.
and the pure C57Bl6 background of our ghrelin-loss-of-function
models may have contributed to the differential outcomes in the
studies.
Zhao and colleagues used very young mice (8 weeks), while our
mice were substantially older (7–8 months) and had substantially
higher initial body weights and fat mass. Notably, in our study
circulating IGF-I levels of WT and all ghrelin loss-of-function mice
were about 4–6 fold higher than those in the investigation by Zhao
et al. [12]. This might suggest an age-related increase in GH in our
study, which could potentially have had a protective anti-
hypoglycemic effect. However, data from Sun et al. [13] do not
suggest that age is a critical factor for the acyl-ghrelin-mediated
maintenance of euglycemia during chronic CR; they did not
observe severe hypoglycemia in 10-week-old GHSR and ghrelin
KO mice (albeit using a slightly milder CR). Two recent studies
suggested that GHSR ablation could even improve aging-
associated obesity and insulin resistance in 16–24-month-old mice,
potentially by reducing adiposity through improved thermogenic
capacity of brown fat and higher lipolytic activity in white adipose
tissue [16,17]. Interestingly, such benefits were not observed in
aged ghrelin-deficient mice [17]. Thus, the true impact of age on
ghrelin-mediated glucose control, or its potential site of action –
production (ghrelin), acylation (GOAT) or signaling (GHSR) –
remains largely unclear. Nevertheless, we believe that the age of
the mice might be a critical factor that could explain the
differential outcomes in our studies.
In conclusion, our data suggest that the GOAT-ghrelin system
is not essential for hypoglycemia prevention during extreme
energy depletion. Prolonged calorie restriction in both male and
female GOAT KO, Ghrelin KO, GHSR KO and Ghrelin GHSR
dKO groups revealed similar overall changes in BW, body fat
mass, and blood glucose levels. Even when body fat mass was
reduced to 0%, all ghrelin loss-of-function mice had similar blood
glucose levels compared to their WT controls, and all mice were
able to survive for at least two days after body fat mass reached
0%. Thus, in contrast to previous results by Zhao et al. [12] and in
agreement with Sun et al. [13], we conclude that protection from
hypoglycemia does not require the GOAT/ghrelin system.
However, subtle differences between experimental designs, the
make up of the diet, the genetic background and most importantly
the age of the mice could explain why Zhao and colleagues may
have found a ‘‘sweet spot’’ of very specific experimental conditions
where they were able to observe and report protective anti-
hypoglycemic effects of acyl-ghrelin, that we and others might
have missed. It remains to be seen if there is an age-dependent
effect of GOAT deficiency on (hypo-)glycemia control in calorie-
restricted conditions. Such age-dependency, if correct, could be an
important novel aspect of ghrelin biology.
Figure 3. Stable blood glucose levels after partial or complete loss of body fat. Even after a partial (2% fat mass; A&B) or complete (0% fat
mass; C&D) loss of body fat, calorie-restricted ghrelin-loss-of-function mice and their WT controls were able to maintain stable blood glucose levels.
Values depict means 6 SEMs from groups of 8 male GOAT WT, 5 female GOAT WT, 9 male GOAT KO, 8 female GOAT KO, 10 male Ghr-GHSR dWT, 20
female Ghr-GHSR dWT, 19 male Ghr KO, 18 female Ghr KO, 7 male GHSR KO, 19 female GHSR KO, 16 male Ghr-GHSR dKO and 7 female Ghr-GHSR dKO
mice.
doi:10.1371/journal.pone.0032100.g003
Ghrelin, Hypoglycemia and CR
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Animals and diet
All studies were approved by and performed according to the
guidelines of the Institutional Animal Care and Use Committee
(IACUC) of the University of Cincinnati. All genetic loss-of-
function models were originally generated at the transgenic mouse
facilities of Taconic (Hudson, NY, USA; GOAT KO) or
Regeneron (Tarrytown, NY, USA; Ghrelin KO, GHSR KO),
and sufficiently backcrossed in our laboratory to ensure a pure
C57Bl6 background. More detailed information on the genetic
modification and metabolic phenotypes can be found in the
original publications [15,18]. All mice (age 7–8 months) were
double-housed on a 12-h light, 12-h dark cycle (6am lights on–
6pm lights off) at 22uC, with restricted access to food as described
below. Mice were fed the standard rodent chow diet LM-485 from
Harlan Teklad Global Diets, with 17% calories from fat, 25%
calories from protein and 58% calories from carbohydrates. In
contrast, Zhao et al used Teklad diet 7002, which was comparable
in calories from fat (18%), but slightly higher in calories from
protein (33%) and poorer in calories from carbohydrates (49%)
[12].
Calorie restriction study
All calorie restriction (CR) studies were conducted based on a
CR paradigm established by Zhao et al. [12]. Before starting CR,
daily ad libitum food intake was monitored for 4 consecutive days in
12 groups of male and female GOAT KO, GOAT WT, ghrelin
KO, GHSR KO, ghrelin/GHSR dKO and ghrelin/GHSR WT
mice. Initial body fat mass and blood glucose concentration were
measured 1 day prior to CR. Subsequently, all groups were
subjected to 60% CR, with 40% of the daily amount (consumed by
the same mouse during the 4 days of acclimation) being given
between 3pm and 4pm. Body weight (at 10am), blood glucose
(2:30–3pm) and fat mass (4–6pm) were measured daily. When
body fat mass reached 2%, blood glucose concentrations were also
measured daily at 8am. Experiments were terminated and animals
rescued when 1) body fat mass reached 0% for two consecutive
days, or 2) blood glucose levels met a predefined hypoglycemia
criteria, i.e. glucose levels ,50 mg/dL for 2 consecutive
measurements. Upon study exclusion blood was drawn from the
submandibular vein.
Blood parameters
Blood glucose was measured using handheld glucometers.
Plasma concentrations of desacyl- and acyl-ghrelin were measured
as previously described [19]. Total IGF-I (mouse high sensitivity
IGF-I, IDS, Boldon, UK) and insulin (Alpco Diagnostics, Salem,
USA) were measured in plasma samples with commercially
available kits as per manufacturer’s instructions.
Body composition analysis
Whole body composition (fat and fat-free mass) was measured
using NMR technology (EchoMRI, Houston, TX).
Statistical analysis
All results are expressed as mean 6 SEM. Statistical
comparisons were performed using unpaired 2-tailed t-tests, one-
way ANOVA with Dunnett’s post-tests, or two-way ANOVA
(GraphPad Prism 5, La Jolla, CA, USA). A p-value below 0.05 was
considered statistically significant.
Supporting Information
Figure S1 Average body weight and fat mass changes in
WT and ghrelin-loss-of-function mice after chronic CR.
Change of body weight and fat mass by chronic CR (40% of ad
libitum calories) in male and female wildtype (WT) and GOAT,
Ghrelin (Ghr), GHSR, or Ghr-GHSR dKO mice. Values are
shown as Mean 6 SEM. Mice were taken out of the CR regiment
when fat mass dropped to 0% for 2 consecutive days, or when
mice became severely hypoglycemic.
(TIF)
Figure S2 Effects of chronic CR on average blood
glucose levels. Chronic CR (40% of ad libitum calories)
decreased glucose levels in male and female wildtype (WT) and
GOAT, Ghrelin (Ghr), GHSR, or Ghr-GHSR dKO mice.
However, ghrelin loss-of function did not increase the risk for
hypoglycemia, compared to the respective WT mice. Values are
shown as Mean 6 SEM. Mice were taken out of the CR regiment
when either fat mass dropped to 0% for 2 consecutive days, or
when mice became hypoglycemic.
(PDF)
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